business.financialpost.com
Medison Biotech Considers Requisition of Special Meeting of Shareholders of Knight Therapeutics Inc.
PETACH TIKVA, Israel — Medison Biotech (1995) Ltd. and its affiliates (“Medison”) own or control more than 10.4 million shares of Knight Therapeutics Inc. (the “Company&rdqu…